|
GLMN expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.360600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.120200E-01 |
| Normal-vs-Stage2 |
9.457800E-01 |
| Normal-vs-Stage3 |
4.953600E-01 |
| Normal-vs-Stage4 |
4.228600E-01 |
| Stage1-vs-Stage2 |
8.067800E-01 |
| Stage1-vs-Stage3 |
3.267000E-01 |
| Stage1-vs-Stage4 |
2.455400E-01 |
| Stage2-vs-Stage3 |
5.540400E-01 |
| Stage2-vs-Stage4 |
4.323400E-01 |
| Stage3-vs-Stage4 |
8.387000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.443800E-01 |
| Normal-vs-AfricanAmerican |
9.696200E-01 |
| Normal-vs-Asian |
9.593500E-02 |
| Caucasian-vs-AfricanAmerican |
8.000200E-01 |
| Caucasian-vs-Asian |
3.201900E-03 |
| AfricanAmerican-vs-Asian |
1.248230E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.025400E-01 |
| Normal-vs-Female |
4.885800E-02 |
| Male-vs-Female |
8.613700E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.740800E-01 |
| Normal-vs-Extreme_Weight |
3.105400E-01 |
| Normal-vs-Obese |
6.118400E-01 |
| Normal-vs-Extreme_Obese |
8.179800E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.054200E-01 |
| Normal_Weight-vs-Obese |
2.420400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.817400E-01 |
| Extreme_Weight-vs-Obese |
5.539600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.679400E-01 |
| Obese-vs-Extreme_Obese |
9.055200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.054200E-02 |
| Normal-vs-Age(41-60Yrs) |
7.480600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.234400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.002300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.947600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.603400E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.962000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.957780E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.736100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.776800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.052420E-01 |
| Normal-VS-Type2 PRCC |
7.432400E-01 |
| Normal-VS-KIRP CIMP |
1.374970E-01 |
| Normal-VS-Unclassified PRCC |
9.828400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.134200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.611800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.150960E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.212800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.493200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.930100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.921000E-01 |
| Normal-vs-N1 |
4.967700E-02 |
| Normal-vs-N2 |
8.224400E-01 |
| N0-vs-N1 |
1.559680E-02 |
| N0-vs-N2 |
8.016800E-01 |
| N1-vs-N2 |
2.856600E-01 |
|
|
